Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: nanotechnology

Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances

Cancer stem cells (CSCs) are a subpopulation of cells that can initiate, self-renew, and sustain tumor growth. CSCs are responsible for tumor metastasis, recurrence, and drug resistance in cancer therapy. CSCs reside within a niche maintained by multiple unique factors in the microenvironment. These factors include hypoxia, excessive levels of angiogenesis, a change of mitochondrial activity from aerobic aspiration to aerobic glycolysis, an upregulated expression of CSC biomarkers and stem cell signaling, and an elevated synthesis of the cytochromes P450 family of enzymes responsible for drug clearance. Antibodies and ligands targeting the unique factors that maintain the niche are utilized for the delivery of anticancer therapeutics to CSCs. In this regard, nanomaterials, specifically nanoparticles (NPs), are extremely useful as carriers for the delivery of anticancer agents to CSCs.

Lipid nanoparticle GM-CSF replacement for autoimmune pulmonary alveolar proteinosis

One of the most-viewed PNAS articles in the last week is “Lipid nanoparticle GM-CSF replacement for autoimmune pulmonary alveolar proteinosis.” Explore the article here: https://ow.ly/QMWH50Yl87H

For more trending articles, visit https://ow.ly/pmKX50Yl87I.

Granulocyte–macrophage colony-stimulating factor (GM-CSF) deficiency drives autoimmune pulmonary alveolar proteinosis (aPAP), a disease characterized by impaired macrophage-mediated clearance of pulmonary surfactants. Clinical data suggest that inhaled recombinant GM-CSF reduces symptoms in aPAP patients, providing a rationale for mRNA-based GM-CSF replacement therapies. However, these require effective mRNA delivery after nebulization. Here, we report the iterative in vivo design of a lipid nanoparticle, named nebulized lung delivery 2 (NLD2), that efficiently delivers mRNA after nebulization. NLD2 carrying GM-CSF mRNA transfected alveolar macrophages in vivo, leading to interleukin-10 pathway activation and subsequent surfactant lipoprotein clearance. In a preclinical disease model of aPAP, GM-CSF mRNA delivery reduced surfactant protein thickness more than recombinant GM-CSF. These data support continued exploration of nebulized lipid nanoparticle therapies for aPAP.

When light ‘thinks’ like the brain: The connection between photons and artificial memory

An international study has revealed a surprising connection between quantum physics and the theoretical models underlying artificial intelligence. The study results from a collaboration between the Institute of Nanotechnology of the National Research Council (Cnr-Nanotec), the Italian Institute of Technology (IIT), and Sapienza University of Rome, together with international research institutions. The research paper was published recently in the journal Physical Review Letters.

Italian researchers show that identical photons propagating within optical circuits spontaneously behave like a Hopfield Network, one of the best-known mathematical models used to describe the associative memory mechanisms of the human brain.

“Instead of using traditional electronic chips, we exploited quantum interference —the phenomenon that occurs in photonic chips when particles of light overlap and interact with one another to encode and retrieve information,” explains Marco Leonetti, coordinator and corresponding author of the study, senior researcher at Cnr-Nanotec and affiliated with the Center for Life Nano-and Neuro-Science at the Italian Institute of Technology (IIT) in Rome. “In this system, photons are not merely carriers of data, but themselves become the ‘neurons’ of an associative memory.”

Hair-width LEDs could eventually replace lasers

LEDs no wider than a human hair could soon take on work traditionally handled by lasers, from moving data inside server racks to powering next-generation displays. New research co-authored by UC Santa Barbara doctoral student Roark Chao points to a practical path forward. The study is published in the journal Optics Express.

“We’re talking about devices that are literally the size of a hair follicle,” said Chao, who studies electrical engineering. “If you can engineer how the light comes out, those microLEDs can start to replace lasers in short-distance data communication.”

The work builds on UCSB’s longstanding strengths in gallium nitride research and optoelectronics. Chao is co-advised by Steven P. DenBaars and Jon A. Schuller, both co-authors on the study, which also includes Nobel laureate Shuji Nakamura, whose pioneering work on blue LEDs transformed global lighting and display technologies. The research was conducted in the laboratories of the DenBaars/Nakamura and Schuller groups, where teams focus on gallium nitride materials growth and nanoscale photonics.

How chronic inflammation rewires macrophages

TIL therapy for glioblastoma.

Tumor infiltrating lymphocyte (TIL) therapy has demonstrated encouraging efficacy in melanoma and nonsmall-cell lung cancer (NSCLC), and is now being explored for glioblastoma despite its immunologically ‘cold’ microenvironment.

Recent studies confirm that functional TILs can be expanded from cold tumors such as glioblastoma, including solid tumor resections and aspirates, overcoming previous feasibility concerns.

Advances in cytokine support, gene editing, and artificial antigen-presenting cells (APCs) are improving TIL persistence, cytotoxicity, and manufacturing scalability.

Focused ultrasound and nanoparticle delivery offer innovative solutions to enhance TIL infiltration across the blood– brain barrier. Integration of spatial multi-omics enables high-resolution mapping of immune niches and identification of tumorreactive clones.

Combination strategies with checkpoint blockade, myeloid modulation, and oncolytic virotherapy are emerging as rational paths to enhance TIL efficacy sciencenewshighlights ScienceMission https://sciencemission.com/TIL-therapy-17895

Continue reading “How chronic inflammation rewires macrophages” | >

Frontiers: Biological membranes are complex, heterogeneous, and dynamic systems that play roles in the compartmentalization and protection of cells from the environment

It is still a challenge to elucidate kinetics and real-time transport routes for molecules through biological membranes in live cells. Currently, by developing and employing super-resolution microscopy; increasing evidence indicates channels and transporter nano-organization and dynamics within membranes play an important role in these regulatory mechanisms. Here we review recent advances and discuss the major advantages and disadvantages of using super-resolution microscopy to investigate protein organization and transport within plasma membranes.

The mammalian plasma membrane (PM) is a complex assembly of lipids and proteins that separates the cell’s interior from the outside environment (Ingolfsson et al., 2014). The multiple collective processes that take place within membranes have a strong impact not only on the cellular behavior but also on its biochemistry. Understanding these processes poses a challenge due to the often complex and multiple interactions among membrane components (Stone et al., 2017). Moreover, the PM surface accommodates different types of lipid and protein clusters (Saka et al., 2014; Owen et al., 2012; Sezgin, 2017), even though the functional role of the clustering on the membrane surface has not yet been fully understood.

Engineered nanoparticles could deliver better targeted cancer treatment to lymph nodes

Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study. The work is published in the journal Proceedings of the National Academy of Sciences.

The experimental approach is designed to treat cancer that has spread to the lymph nodes, a difficult-to-treat stage of the disease. Today, most immunotherapies are delivered by intravenous (IV) infusion and circulate throughout the body. This can trigger immune responses in healthy tissues, leading to serious side effects.

“Some immunotherapies cause such severe side effects that clinicians are forced to lower the dose, making treatment less effective,” said senior author Guojun Chen, Assistant Professor in McGill’s Department of Biomedical Engineering and member of the Goodman Cancer Institute. “Our approach could allow for higher, more effective doses while limiting toxicity, which is a major goal in cancer treatment.”

Nanotubes unlock new wavelengths for smarter sensing

Sensors made of carbon nanotubes that can measure infrared and terahertz radiation are being tested for uses ranging from detecting damaged cables after earthquakes, to collecting health data via ultrathin wearable devices, and assisting with pharmaceutical quality control, say researchers in Japan.

“Accurately visualizing the internal structures of organisms and objects is integral to our daily lives, from medical imaging to security scanning in airports,” and terahertz sensors built from carbon nanotubes are uniquely suited to this purpose, says Yukio Kawano is a professor of engineering at Chuo University in Tokyo, and project leader at the Kanagawa Institute of Industrial Science and Technology (KISTEC) in Japan.

Compared with many sensor technologies that can only detect one part of the electromagnetic spectrum, Kawano’s team is working to create sensors that can detect terahertz and a broader range of radiation, and use them to produce high-resolution images.

Groundbreaking 2D Nanomaterial Rolls Into a New Dimension

MXene nanoscrolls transform flat 2D materials into conductive 1D structures, unlocking advances in energy storage, sensing, wearables, and superconductivity. Nearly 15 years after identifying a versatile two-dimensional conductive nanomaterial known as MXene, researchers at Drexel University have

Sometimes less is more: Messier nanoparticles may actually deliver drugs more effectively than tightly packed ones

The tiny fatty capsules that deliver COVID-19 mRNA vaccines into billions of arms may work better when they’re a little disorganized. That’s the surprising finding from researchers who developed a new way to examine these drug-delivery vehicles one particle at a time—revealing that cramming in more medicine doesn’t always mean better results.

The research was presented at the 70th Biophysical Society Annual Meeting, held in San Francisco from February 21–25, 2026.

Lipid nanoparticles, or LNPs, are microscopic bubbles of fat that can ferry fragile RNA molecules into cells. They were crucial to the success of mRNA vaccines, and scientists are now working to use them to deliver treatments for cancer, genetic diseases, and other conditions. But there’s a problem: only about 1% to 5% of the cargo inside LNPs actually gets released inside cells.

/* */